| Filed On | Filing |
|---|---|
| 18 Sep 2026 |
Form 4/A: Hopman Mark, Chief Commercial Officer
Sold 35,994 shares ($665K) |
| 02 Jul 2026 |
Form 4/A: Feider Stephen, Chief Financial Officer
Received 5,104 shares by exercise or conversion ($26K) · Sold 5,104 shares ($87K) · Received 4,896 shares by exercise or conversion ($25K) · 1 more |
| 13 Mar 2026 |
Form 4/A: Mensinger Mike, Chief Product Officer
Granted 91,520 Employee Stock Option (right to buy) |
| 13 Mar 2026 |
Form 4/A: Russell Steven Jon, Chief Medical Officer
Granted 91,520 Employee Stock Option (right to buy) |
| 13 Mar 2026 |
Form 4/A: Saint Sean, Director
Granted 287,944 Employee Stock Option (right to buy) |
| 13 Mar 2026 |
Form 4/A: Hopman Mark, Chief Commercial Officer
Granted 91,520 Employee Stock Option (right to buy) |
| 13 Mar 2026 |
Form 4/A: Feider Stephen, Chief Financial Officer
Granted 110,342 Employee Stock Option (right to buy) |
Loading...